Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

The Effect of Health Education Conducted Using Two Different Methods on Individuals in a High-risk Age Group Regarding Their Health Beliefs and Attitudes Towards Colorectal Cancer Screening, and Their Participation in the Screening Program

11 de noviembre de 2026 actualizado por: Serpil Özdemir, Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

Colorectal cancer is the third most common type of cancer worldwide and can be fatal if not diagnosed early. Screening tests, such as the fecal occult blood test, help detect colorectal cancer at an early stage, which increases the chances of successful treatment. However, many people do not undergo regular screenings due to fear, a lack of information, or other barriers. This study examines two different methods used to inform individuals aged 50-70 about colorectal cancer screening: traditional health education and a counseling approach known as "motivational interviewing." Motivational interviewing helps individuals feel more confident and willing to undergo screening by encouraging them to talk about their concerns and guiding them toward making positive decisions. The aim of the study is to determine which method is more effective in improving individuals' health-related beliefs and attitudes regarding colorectal cancer, as well as their actual participation in screening programs. The findings will help us enhance the support we provide to individuals in safeguarding their health.

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Descripción detallada

Cancer is a chronic disease characterized by uncontrolled cell proliferation, which impairs health by affecting the functions of tissues, organs, and bodily systems, and leads to morbidity and mortality. Globally, approximately 10 million deaths occur each year-meaning one in every six deaths is directly attributable to cancer-making it the second leading cause of death overall. According to reports from international authorities for 2022, colorectal cancer (CRC) is the second most common cause of cancer-related deaths. In 2022, approximately 1.9 million new cases of CRC were diagnosed worldwide, resulting in nearly one million deaths. Projections indicate that by 2045, the incidence of CRC will increase by 70%, with the total number of cases rising to 3.29 million; meanwhile, CRC-related mortality is expected to climb by 83%, reaching a total of 1.66 million deaths per year. In Turkey, CRC is the third most common type of cancer and ranks among the primary cancers responsible for more than 10,000 deaths annually.

Colorectal cancer is a significant and priority public health issue; it is prevalent, frequently leads to disability and death, and exerts a negative impact on the health of individuals, families, and society-encompassing biopsychosocial and economic dimensions. At the individual and family levels, CRC impairs physical, psychological, and social well-being, while also placing a strain on family finances. From a societal perspective, CRC imposes a substantial burden on the national economy by significantly increasing the utilization of healthcare services, driving up treatment and care costs, and resulting in reduced productivity and losses in the workforce. Studies indicate that various genetic, biological, behavioral, and environmental factors-such as family history, lifestyle habits, and chronic intestinal inflammation-serve as risk factors for the development of CRC.

Although the colorectal cancer (CRC) screening program in our country is easy to access and free of charge for high-risk groups, participation rates remain low. The literature identifies several reasons for this, including a lack of knowledge about screening programs and cancer symptoms, a low perception of risk, the absence of current physical complaints, feelings of embarrassment, a lack of time, insufficient information provided by healthcare personnel, a lack of motivation, and negative attitudes or beliefs regarding screening. Given the complexity of the factors that determine whether an individual participates in screening, it is essential to examine the health beliefs of those at risk. Health beliefs are among the most fundamental factors shaping an individual's health-related behaviors. To improve participation in screening among individuals in high-risk age groups, it is recommended that the factors influencing these behaviors be identified and positively reinforced. Nurses play a significant role and bear a major responsibility in identifying the specific health beliefs that influence participation in the CRC screening program.

Motivation is an internal state-influenced by external factors-that signifies a readiness for change; it is a client-centered approach. The objective here is to enhance an individual's intrinsic motivation to facilitate action. A review of the existing literature reveals a limited number of studies in our country that utilize standard health education or motivational interviewing-based health education to increase participation in national cancer screening programs. Furthermore, there are no studies that employ motivational interviewing and the Health Belief Model (HBM) to examine the impact on health beliefs, attitudes, and participation regarding colorectal cancer (CRC) screening programs. The health education and counseling intervention in this study is grounded in the theoretical framework of the Health Belief Model. Accordingly, the intervention content is designed to encompass the following components: perceived susceptibility, perceived severity, perceived benefits, perceived barriers, and perceived self-efficacy. The intervention aims to increase participants' perceived susceptibility to developing CRC, as well as their perception of the severity of the potential health consequences should they develop the disease. Additionally, the intervention seeks to strengthen participants' perceptions of the benefits-specifically, the protective effect of early detection and treatment of CRC through regular screening-while simultaneously reducing perceived barriers to participation and enhancing self-efficacy regarding their capacity to undergo the necessary screening procedures. It is anticipated that the health education intervention, developed based on this theoretical foundation, will bring about positive changes in the participants' health beliefs and attitudes regarding their regular participation in the colorectal cancer (CRC) screening program.

Tipo de estudio

Intervencionista

Inscripción (Actual)

120

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Etlik
      • Ankara, Etlik, Turquía (Türkiye), 06018
        • Elife Mehmet Kahraman Family Health Center, Ankara, Yenimahalle
    • Yenimahalle
      • Ankara, Yenimahalle, Turquía (Türkiye), 06200
        • Elife Mehmet Kahraman Family Health Center, Ankara, Yenimahalle

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

50 años a 70 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria: Being willing to participate in the research, Being between the ages of 50 and 70, Having completed at least primary education, Scoring 24 or higher on the Standardized Mini-Mental State Examination (for individuals over the age of 65), Being registered at the Family Health Center where the study is conducted, Being an active user of the WhatsApp application on one's mobile phone

Exclusion Criteria: Having a diagnosed bowel disease (such as inflammatory bowel disease, Crohn's disease, ulcerative colitis, etc.), Having a history of colorectal cancer in first-degree relatives, Being a healthcare professional, Having undergone colorectal cancer screening within the last two years, Having a condition that hinders verbal or written communication, Having an orthopedic impairment that prevents the completion of questionnaires, Having a mental health disorder or condition, Residing in a nursing home or other social care institution, Having previously received education regarding colorectal cancer screening.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Health Education Group

Arm Description: Participants will be involved in structured educational sessions focused on increasing their knowledge about colorectal cancer, its risk factors, and the importance of early screening.

Structured group education focusing on colorectal cancer awareness, risk reduction, and early detection.

Experimental: Motivational Interviewing Group

Participants will take part in one-on-one counseling sessions that utilize motivational interviewing techniques, with the aim of increasing motivation and reducing barriers to colorectal cancer screening.

Individual counseling sessions using motivational interviewing to enhance screening behavior.

Sin intervención: Control Group

Participants will not receive any intervention during the study period.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
1. Participation Rate in Colorectal Cancer Screening
Periodo de tiempo: Baseline and 1 month after intervention

The proportion of individuals who undergo colorectal cancer screening within 1 months following the educational/motivational interviewing intervention; this will be assessed using health records and surveys.

Baseline and 1 month after intervention

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de noviembre de 2026

Finalización primaria (Actual)

10 de noviembre de 2026

Finalización del estudio (Actual)

10 de noviembre de 2026

Fechas de registro del estudio

Enviado por primera vez

11 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

11 de noviembre de 2026

Publicado por primera vez (Actual)

17 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

11 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • Colorectal Cancer

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .